I-MAB (NAS:IMAB)
$ 1.055 -0.04 (-3.64%) Market Cap: 81.84 Mil Enterprise Value: -118.19 Mil PE Ratio: 0 PB Ratio: 0.35 GF Score: 35/100

I-Mab Company Update Conference Call Transcript

Sep 04, 2020 / 12:00PM GMT
Release Date Price: $37.07 (+3.63%)
Operator

Good day, and welcome to the I-Mab Company Update Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Jielun Zhu, Chief Financial Officer. Please go ahead.

Jielun Zhu
I-Mab - CFO & Director

Okay. Thank you, operator. Hi, everyone. Good night or good morning, depending on where you are.

Earlier today, we have made 2 important announcements regarding a strategic partnership we signed with AbbVie and also a private placement transaction we signed with the consortium of investors led by Hillhouse. We would like to host this conference call to explain more details to you about these 2 transactions.

Now joining me today on the call is Dr. Jingwu Zang, Founder, Honorary Chairman and Director of I-Mab. I would like to turn the call over to Dr. Zang right now, and I will take over after he speaks.

Dr. Zang?

Jingwu Zhang Zang
I-Mab - Founder, Honorary Chairman & Director

Thank you, Jielun, and thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot